The Effectiveness of Lifestyle Interventions to Reduce Side Effects of Androgen Deprivation Therapy for Men with Prostate Cancer: a Systematic Review

Overview

Journal Qual Life Res

Specialties Pharmacology
Rehabilitation Medicine

Date 2019 Dec 14

PMID 31832978

Citations 5

Authors

Maud J M Geerkens

Nieck S A Pouwels

Harry P Beerlage

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this review is to systematically review randomized controlled trials on lifestyle interventions on PCa patients undergoing androgen deprivation therapy.

Methods: A literature search was conducted using the electronic databases Medline and PubMed. To be eligible, studies had to be randomized controlled trials (RCTs) that focused on side effects of ADT and lifestyle interventions to reduce side effects for men undergoing ADT with PCa. Lifestyle interventions were defined as interventions that included any dietary or behavioral components.

Results: Twenty-nine trials were included. Most of them focused on exercise interventions, while some investigated the effect of dietary or behavioral interventions. The effect of different lifestyle influencing modalities aimed to improve on the adverse effects of ADT varied greatly.

Conclusions: It is not possible to draw one conclusion on the effect of exercise-based interventions, but noted on several adverse effects of ADT improvement. Further studies are necessary to develop personalized lifestyle interventions in order to mitigate the adverse effects.

Citing Articles

Associations of role, area deprivation index, and race with health behaviors and body mass index among localized prostate cancer patients and their partners.

Xu J, Ma C, Hirschey R, Liu J, Neidre D, Nielsen M J Cancer Surviv. 2024; .

PMID: 38888710 DOI: 10.1007/s11764-024-01625-z.

Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX data.

Gomaa S, Kelly W, Mitchell E, Storozynsky E, Zeigler-Johnson C, Juon H World J Urol. 2023; 41(9):2351-2357.

PMID: 37555986 DOI: 10.1007/s00345-023-04531-8.

Jackson M, Walker E, Tulloch-Reid M Qual Life Res. 2022; 31(12):3391-3401.

PMID: 35900615 DOI: 10.1007/s11136-022-03202-2.

Randomised controlled trial to investigate the effectiveness of the symptom management after radiotherapy (SMaRT) group intervention to ameliorate lower urinary tract symptoms in men treated for prostate cancer.

Faithfull S, Cockle-Hearne J, Lemanska A, Otter S, Skene S Support Care Cancer. 2021; 30(4):3165-3176.

PMID: 34932140 PMC: 8857109. DOI: 10.1007/s00520-021-06749-x.

Effects of leuprolide acetate on the quality of life of patients with prostate cancer: A prospective longitudinal cohort study.

Kim M, Jung S, Chung H, Hwang E, Kwon D Prostate Int. 2021; 9(3):132-139.

PMID: 34692585 PMC: 8498686. DOI: 10.1016/j.prnil.2020.11.001.

References

Sharma P, Wisniewski A, Braga-Basaria M, Xu X, Yep M, Denmeade S . Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy. J Urol. 2009; 182(5):2265-72. PMC: 3089061. DOI: 10.1016/j.juro.2009.07.030. View

Bourke L, Gilbert S, Hooper R, Steed L, Joshi M, Catto J . Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol. 2013; 65(5):865-72. DOI: 10.1016/j.eururo.2013.09.040. View

Taylor L, Canfield S, Du X . Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer. 2009; 115(11):2388-99. DOI: 10.1002/cncr.24283. View

Nilsen T, Raastad T, Skovlund E, Courneya K, Langberg C, Lilleby W . Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy. Acta Oncol. 2015; 54(10):1805-13. DOI: 10.3109/0284186X.2015.1037008. View

Datta M, Schwartz G . Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical review. Oncologist. 2012; 17(9):1171-9. PMC: 3448410. DOI: 10.1634/theoncologist.2012-0051. View

Gardner J, Livingston P, Fraser S . Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol. 2013; 32(4):335-46. DOI: 10.1200/JCO.2013.49.5523. View

Nead K, Sinha S, Yang D, Nguyen P . Association of androgen deprivation therapy and depression in the treatment of prostate cancer: A systematic review and meta-analysis. Urol Oncol. 2017; 35(11):664.e1-664.e9. DOI: 10.1016/j.urolonc.2017.07.016. View

Gilbert S, Tew G, Fairhurst C, Bourke L, Saxton J, Winter E . Effects of a lifestyle intervention on endothelial function in men on long-term androgen deprivation therapy for prostate cancer. Br J Cancer. 2016; 114(4):401-8. PMC: 4815775. DOI: 10.1038/bjc.2015.479. View

Heidenreich A, Bastian P, Bellmunt J, Bolla M, Joniau S, van der Kwast T . EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol. 2013; 65(2):467-79. DOI: 10.1016/j.eururo.2013.11.002. View

10.

Uth J, Hornstrup T, Christensen J, Christensen K, Jorgensen N, Helge E . Football training in men with prostate cancer undergoing androgen deprivation therapy: activity profile and short-term skeletal and postural balance adaptations. Eur J Appl Physiol. 2015; 116(3):471-80. DOI: 10.1007/s00421-015-3301-y. View

11.

Taaffe D, Newton R, Spry N, Joseph D, Chambers S, Gardiner R . Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial. Eur Urol. 2017; 72(2):293-299. DOI: 10.1016/j.eururo.2017.02.019. View

12.

Uth J, Hornstrup T, Christensen J, Christensen K, Jorgensen N, Schmidt J . Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial. Osteoporos Int. 2015; 27(4):1507-1518. DOI: 10.1007/s00198-015-3399-0. View

13.

Cermak N, Res P, de Groot L, Saris W, van Loon L . Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis. Am J Clin Nutr. 2012; 96(6):1454-64. DOI: 10.3945/ajcn.112.037556. View

14.

Cormie P, Newton R, Taaffe D, Spry N, Joseph D, Hamid M . Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial. Prostate Cancer Prostatic Dis. 2013; 16(2):170-5. DOI: 10.1038/pcan.2012.52. View

15.

Yunfeng G, Weiyang H, Xueyang H, Yilong H, Xin G . Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis. Medicine (Baltimore). 2017; 96(27):e7368. PMC: 5502159. DOI: 10.1097/MD.0000000000007368. View

16.

Sajid S, Dale W, Mustian K, Kotwal A, Heckler C, Porto M . Novel physical activity interventions for older patients with prostate cancer on hormone therapy: A pilot randomized study. J Geriatr Oncol. 2016; 7(2):71-80. PMC: 4818675. DOI: 10.1016/j.jgo.2016.02.002. View

17.

Winters-Stone K, Dobek J, Bennett J, Dieckmann N, Maddalozzo G, Ryan C . Resistance training reduces disability in prostate cancer survivors on androgen deprivation therapy: evidence from a randomized controlled trial. Arch Phys Med Rehabil. 2014; 96(1):7-14. PMC: 4433162. DOI: 10.1016/j.apmr.2014.08.010. View

18.

Dawson J, Dorff T, Schroeder E, Lane C, Gross M, Dieli-Conwright C . Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial. BMC Cancer. 2018; 18(1):368. PMC: 5883585. DOI: 10.1186/s12885-018-4306-9. View

19.

Cormie P, Galvao D, Spry N, Joseph D, Chee R, Taaffe D . Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial. BJU Int. 2014; 115(2):256-66. DOI: 10.1111/bju.12646. View

20.

Vitolins M, Griffin L, Tomlinson W, Vuky J, Adams P, Moose D . Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer. J Clin Oncol. 2013; 31(32):4092-8. PMC: 3816959. DOI: 10.1200/JCO.2012.48.1432. View